Bariatric Surgery for Obesity Management
Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 30 (estimated)
- Sponsor
- Mayo Clinic · Other
This trial is looking for people with obesity who want to understand how weight loss affects insulin and fat breakdown. Participants will be studied before and after having bariatric surgery.
You may be able to join if
- I have a BMI between 40 and 50
- I do not have any active illness that interferes with mobility
You may not be able to join if
- I have been diagnosed with Type 1 or Type 2 diabetes
- I have active coronary artery disease
- I participate in structured exercise more than 2 times a week
- I smoke
- I take medications that affect fat metabolism
- I have kidney problems
- I have chronic liver disease
- I am pregnant or breastfeeding
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityIt is not known how much improvement in insulin regulated lipolysis (the breakdown of triglycerides) occurs following substantial, sustained weight loss. Researchers will test the effects of inflammation and lipolysis regulation in people before and after bariatric surgery (sleeve gastrectomy) to answer these questions.
Loading trial locations…
No contact information available.